Inhibitory effect of hederagenin on the proliferation of bladder cancer cells in vitro and in nude mice through the JNK/p38 MAPK signaling pathway
10.3760/cma.j.cn.115807-20211215-00391
- VernacularTitle:常春藤皂苷元通过JNK/p38 MAPK信号通路抑制膀胱癌细胞体外和裸鼠体内增殖能力的相关研究
- Author:
Tielin WU
1
;
Sheng LI
;
Sen YANG
Author Information
1. 宁波市医疗中心李惠利医院泌尿外科，宁波 325000
- Keywords:
Bladder cancer;
Hederagenin;
JNK/p38 MAPK signaling pathway
- From:
Chinese Journal of Endocrine Surgery
2022;16(6):681-684
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the effect of hederagenin (HE) on the proliferation of bladder cancer cell T24 in vitro and in nude mice.Methods:Human bladder cancer cells T24 were divided into control group and experimental group. The experimental group was cultured with DMEM medium containing 25μg/mL hederogenin, and CCK8 was used to detect cell proliferation ability. Nude mice were divided into a control group and an experimental group and injected with T24 cells. The cells of the experimental group were injected with ivy sapogenin at 30 mg/kg every other day. The protein of T24 cells and tumor mass was extracted to detect the expression of p-JNK/JNK and p-p38/p38.Results:After the bladder cancer cells T24 were treated with hederagenin, the CCK8 results showed that the cell proliferation ability of the experimental group was significantly decreased ( P<0.05) . The expression levels of p-JNK in experimental group and control group were 0.21±0.06 and 0.89±0.15, respectively, and the expression levels of p-p38 were 0.38±0.09 and 1.44±0.26, respectively. The expressions of p-JNK and p-p38 were up-regulated (all P<0.05) . In vivo, it was found that after treatment with ivisaponin, the volume of tumor mass were 1192.07±250.92μm 3 in the subcutaneous tumor experimental group and 2280.50±600.1μm 3 in the control group, and the mass were 0.65±0.29g and 1.62±0.38g, respectively. The mass and volume of the experimental group were decreased (all P<0.05) . We extracted mass proteins, and western blotting results showed that the expression levels of p-JNK in the experimental group and control group were 0.38±0.08 and 1.03±0.19, respectively, and the expression levels of p-p38 were 0.71±0.12 and 1.36±0.25, respectively. The expressions of p-JNK and p-p38 were up-regulated (all P<0.05) . Conclusion:Hederagenin inhibits the proliferation of bladder cancer in vitro and in nude mice through the JNK/p38 MAPK signaling pathway.
